Abcam Receives Multiple Takeover Approaches Amidst Growing Polyclonal Antibodies Market

 On June 30, 2023, Abcam, a renowned biotechnology supplier based in the UK, found itself at the center of attention as it received multiple takeover approaches from various companies. Among the interested parties were Danaher, Agilent Technologies, and Germany’s Merck KGaA. This news caused a significant surge in Abcam’s ADRs, with a 4% increase. It is worth mentioning that Danaher had previously abandoned a takeover pursuit of another company called Catalent.

The growing global polyclonal antibodies market, which is projected to witness a 4% compound annual growth rate (CAGR) by 2029, could potentially contribute to the heightened interest in Abcam.

https://beststocks.com/abcam-receives-multiple-takeover-approaches-a/